Effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata

Archives of Ophthalmology

Volumn 125, Issue 10, 2007, Pages 1345-1350

  Wirtitsch, Matthias G ^a   Findl, Oliver ^a,b   Heinzl, Harald ^a   Drexler, Wolfgang ^a,c  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBONATE DEHYDRATASE II; DORZOLAMIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORNEA; CORNEA DISEASE; CORNEA GUTTATA; DRUG EFFECT; ENZYME INHIBITION; HUMAN; MALE; MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SLIT LAMP; TREATMENT OUTCOME; VISION;

AGED; AGED, 80 AND OVER; BODY WEIGHTS AND MEASURES; CARBONIC ANHYDRASE INHIBITORS; CELL COUNT; CORNEA; CORNEAL DISEASES; CORNEAL EDEMA; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ENDOTHELIUM, CORNEAL; FEMALE; HUMANS; INTERFEROMETRY; INTRAOCULAR PRESSURE; LIGHT; MALE; MIDDLE AGED; SULFONAMIDES; THIOPHENES; TONOMETRY, OCULAR;

EID: 35348937202     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.125.10.1345     Document Type: Article

References (29)

1. Lippa EA, Schuman JS, Higginbotham EJ, et al. MK-507 versus sezolamide: comparative efficacy of two topically active carbonic anhydrase inhibitors. Ophthalmology. 1991;98(3):308-312.
2. Lippa EA, Carlson LE, Ehinger B, et al. Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1992;110(4):495-499.
3. Simpson AJ, Gray TB, Ballantyne C. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study. Aust N Z J Ophthalmol. 1996;24 (1):39-42.
4. Strahlman E, Tipping R, Vogel R. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension: Dorzolamide Dose-Response Study Group. Am J Ophthalmol. 1996;122(2):183-194.
5. Wistrand PJ, Schenholm M, Lonnerholm G. Carbonic anhydrase isoenzymes CA I and CA II in the human eye. Invest Ophthalmol Vis Sci. 1986;27(3):419-428.
6. Wistrand J. Distribution and function of carbonic anhydrase (CA) isoenzymes in the human eye: relevance for the design of topical CA inhibitors. Exp Eye Res. 1992;55(suppl 1):185.
7. Hageman GS, Zhu XL, Waheed A, Sly WS. Localization of carbonic anhydrase IV in a specific capillary bed of the human eye. Proc Natl Acad Sci U S A. 1991;88(7):2716-2720.
8. Ridderstrale Y, Wistrand PJ, Brechue WF. Membrane-associated CA activity in the eye of the CA II-deficient mouse. Invest Ophthalmol Vis Sci. 1994;35(5):2577-2584.
9. Pfeiffer N. Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor. Surv Ophthalmol. 1997;42(2):137-151.
10. Wilkerson M, Cyrlin M, Lippa EA, et al. Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor. Arch Ophthalmol. 1993;111(10):1343-1350.
11. Uva MG, Russo V, Longo A, Ott JP, Reibaldi A. 2% dorzolamide and cornea: an ultrabiomicroscopic study. Acta Ophthalmol Scand Suppl. 1997;(224):23-24.
12. Egan CA, Hodge DO, McLaren JW, Bourne WM. Effect of dorzolamide on corneal endothelial function in normal human eyes. Invest Ophthalmol Vis Sci. 1998;39(1):23-29.
13. Kaminski S, Hommer A, Koyuncu D, Biowski R, Barisani T, Baumgartner I. Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility. Acta Ophthalmol Scand. 1998;76(1):78-79.
14. Lass JH, Khosrof SA, Laurence JK, Horwitz B, Ghosh K, Adamsons I. A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol: Dorzolamide Corneal Effects Study Group. Arch Ophthalmol. 1998;116(8):1003-1010.
15. Giasson CJ, Nguyen TQ, Boisjoly HM, Lesk MR, Amyot M, Charest M. Dorzolamide and corneal recovery from edema in patients with glaucoma or ocular hypertension. Am J Ophthalmol. 2000;129(2):144-150.
16. Konowal A, Morrison JC, Brown SV, et al. Irreversible corneal decompensation in patients treated with topical dorzolamide. Am J Ophthalmol. 1999;127(4):403-406.
17. Inoue K, Okugawa K, Oshika T, Amano S. Influence of dorzolamide on corneal endothelium. Jpn J Ophthalmol. 2003;47(2):129-133.
18. Wirtitsch MG, Findl O, Kiss B, Petternel V, Heinzl H, Drexler W. Short-term effect of dorzolamide hydrochloride on central corneal thickness in humans with cornea guttata. Arch Ophthalmol. 2003;121(5):621-625.
19. Sacu S, Findl O, Buehl W, Kiss B, Gleiss A, Drexler W. Optical biometry of the anterior eye segment: interexaminer and intraexaminer reliability of ACMaster. J Cataract Refract Surg. 2005;31(12):2334-2339.
20. Goldmann H, Schmidt T. Applanation tonometry [in German]. Ophthalmologica. 1957;134(4):221-242.
21. Herndon LW, Choudhri SA, Cox T, Damji KF, Shields MB, Allingham RR. Central corneal thickness in normal, glaucomatous, and ocular hypertensive eyes. Arch Ophthalmol. 1997;115(9):1137-1141.
22. Gordon A, Boggess EA, Molinari JF. Variability of ultrasonic pachometry. Optom Vis Sci. 1990;67(3):162-165.
23. Nemeth G, Vajas A, Kolozsvari B, Berta A, Modis L Jr. Anterior chamber depth measurements in phakic and pseudophakic eyes: pentacam versus ultrasound device. J Cataract Refract Surg. 2006;32(8):1331-1335.
24. Fercher AF, Roth E. Ophthalmic laser interferometry. Proc Soc Photo Opt Instrum Eng. 1986;658:48-51.
25. Fercher AF, Mengedoht K, Werner W. Eye length measurement by interferometry with partially coherent light. Opt Lett. 1988;13(3):186-188.
26. Drexler W, Baumgartner A, Findl O, Hitzenberger CK, Sattmann H, Fercher AF. Submicrometer precision biometry of the anterior segment of the human eye. Invest Ophthalmol Vis Sci. 1997;38(7):1304-1313.
27. Kuang KY, Xu M, Koniarek JP, Fischbarg J. Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit corneal endothelium. Exp Eye Res. 1990;50(5):487-493.
28. Bonanno JA. Identity and regulation of ion transport mechanisms in the corneal endothelium. Prog Retin Eye Res. 2003;22(1):69-94.
29. Echevarria M, Kuang K, Iserovich P, et al. Cultured bovine corneal endothelial cells express CHIP28 water channels. Am J Physiol. 1993;265(5, pt 1):C1349-C1355.